Загрузка...
Romidepsin Controls Chronic Lymphocytic Leukemia in a Patient with Mycosis Fungoides
Romidepsin belongs to a class of medications called histone deacetylase inhibitors and is currently approved for treatment of cutaneous and peripheral T-cell lymphomas. Romidepsin was previously investigated for the treatment of chronic lymphocytic leukemia (CLL), and demonstrated potential benefit,...
Сохранить в:
| Опубликовано в: : | Hematol Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
PAGEPress Publications, Pavia, Italy
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5136743/ https://ncbi.nlm.nih.gov/pubmed/27994839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2016.6840 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|